ZA915723B - 1-(substituted pyridinylamino)-1h-indol-5-yl-substituted carbamates,a process and intermediates for their preparation and their use as medicaments - Google Patents

1-(substituted pyridinylamino)-1h-indol-5-yl-substituted carbamates,a process and intermediates for their preparation and their use as medicaments

Info

Publication number
ZA915723B
ZA915723B ZA915723A ZA915723A ZA915723B ZA 915723 B ZA915723 B ZA 915723B ZA 915723 A ZA915723 A ZA 915723A ZA 915723 A ZA915723 A ZA 915723A ZA 915723 B ZA915723 B ZA 915723B
Authority
ZA
South Africa
Prior art keywords
loweralkyl
hydrogen
substituted
arylloweralkyl
indol
Prior art date
Application number
ZA915723A
Other languages
English (en)
Inventor
Richard Charles Effland
Charles Effland Richard
Gordon Edward Olsen
Edward Olsen Gordon
David Gordon Wettlaufer
Gordon Wettlaufer David
Larry Davis
Davis Larry
Joseph Thomas Klein
Thomas Klein Joseph
Peter Allen Nemoto
Allen Nemoto Peter
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA915723B publication Critical patent/ZA915723B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA915723A 1990-07-23 1991-07-22 1-(substituted pyridinylamino)-1h-indol-5-yl-substituted carbamates,a process and intermediates for their preparation and their use as medicaments ZA915723B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/555,890 US5102891A (en) 1990-07-23 1990-07-23 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates

Publications (1)

Publication Number Publication Date
ZA915723B true ZA915723B (en) 1992-04-29

Family

ID=24218998

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915723A ZA915723B (en) 1990-07-23 1991-07-22 1-(substituted pyridinylamino)-1h-indol-5-yl-substituted carbamates,a process and intermediates for their preparation and their use as medicaments

Country Status (23)

Country Link
US (1) US5102891A (no)
EP (1) EP0468401B1 (no)
JP (1) JP2564714B2 (no)
KR (1) KR100201515B1 (no)
AT (1) ATE171176T1 (no)
AU (1) AU639581B2 (no)
BR (1) BR1100534A (no)
CA (1) CA2047531C (no)
CZ (1) CZ283253B6 (no)
DE (1) DE69130196T2 (no)
DK (1) DK0468401T3 (no)
ES (1) ES2121761T3 (no)
FI (1) FI102067B1 (no)
HU (1) HUT58317A (no)
IE (1) IE912567A1 (no)
IL (1) IL98920A (no)
MX (1) MX9100342A (no)
NO (1) NO300132B1 (no)
NZ (1) NZ239038A (no)
PL (1) PL291185A1 (no)
PT (1) PT98413B (no)
SG (1) SG48059A1 (no)
ZA (1) ZA915723B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
CZ284437B6 (cs) * 1991-04-17 1998-11-11 Hoechst Marion Roussel, Inc. Substituované (pyridinylamino)-benzisoxazoly a -benzo[b]thiofeny, způsob jejich přípravy farmaceutický prostředek obsahující tyto sloučeniny a použití těchto sloučenin
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
BR9714189A (pt) * 1996-12-27 2000-02-29 Hoechst Marion Roussel Inc N-(piridinilamino) isoindolinas e compostos relacionados
US6004977A (en) * 1996-12-27 1999-12-21 Hoechst Marion Roussel, Inc. N-(pyridinylamino) isoindolines and related compounds
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2888238B1 (fr) * 2005-07-07 2007-09-07 Servier Lab Nouveaux derives 1h-indole-pyridinecarboxamides et 1h-indole-piperidinecarboxamide, leur procede de preparation et les compositions pharceumatiques qui les contiennent.
JP6082250B2 (ja) * 2010-02-09 2017-02-15 ザ・ジョンズ・ホプキンス・ユニバーシティー 認知機能を改善するための方法および組成物
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US4992448A (en) * 1989-10-24 1991-02-12 Hoechst-Roussel Pharmaceuticals Inc. Benzocycloalkylaminopyridinamines and related compounds as topical antiinflammatory agents for the treatment of skin disorders

Also Published As

Publication number Publication date
NZ239038A (en) 1994-04-27
MX9100342A (es) 1992-02-28
FI102067B (fi) 1998-10-15
NO912866D0 (no) 1991-07-22
JP2564714B2 (ja) 1996-12-18
EP0468401A3 (en) 1992-07-29
HUT58317A (en) 1992-02-28
FI913502A (fi) 1992-01-24
BR1100534A (pt) 2000-03-14
PT98413A (pt) 1992-05-29
NO300132B1 (no) 1997-04-14
DE69130196D1 (de) 1998-10-22
ATE171176T1 (de) 1998-10-15
EP0468401A2 (en) 1992-01-29
AU8121691A (en) 1992-01-30
JPH04243878A (ja) 1992-08-31
FI102067B1 (fi) 1998-10-15
KR920002585A (ko) 1992-02-28
HU912450D0 (en) 1991-12-30
KR100201515B1 (ko) 1999-06-15
PL291185A1 (en) 1993-04-05
SG48059A1 (en) 1998-04-17
CA2047531C (en) 2003-01-07
IL98920A (en) 1995-08-31
ES2121761T3 (es) 1998-12-16
CA2047531A1 (en) 1992-01-24
EP0468401B1 (en) 1998-09-16
IE912567A1 (en) 1992-01-29
AU639581B2 (en) 1993-07-29
DK0468401T3 (da) 1999-06-14
NO912866L (no) 1992-01-24
FI913502A0 (fi) 1991-07-19
PT98413B (pt) 1999-01-29
CZ283253B6 (cs) 1998-02-18
US5102891A (en) 1992-04-07
CS228191A3 (en) 1992-02-19
DE69130196T2 (de) 1999-04-01

Similar Documents

Publication Publication Date Title
ZA915723B (en) 1-(substituted pyridinylamino)-1h-indol-5-yl-substituted carbamates,a process and intermediates for their preparation and their use as medicaments
IL101589A0 (en) 1-(pyrido(3,4,b)-1,4-oxazinyl-4-yl)-1h-indoles,intermediates and a process for their preparation,and their use as medicaments
PL291408A1 (en) Method of obtaining novel 1-(pyridinylalkylo)-1h-indoles
NO902556L (no) 4,5,5a,6-tetrahydro-3h-isoksazol(5,4,3-kl)akridinderivater og fremgangsmaate for fremstilling derav.
DK0471298T3 (da) Carbamoyl-1-(pyridinylalkyl)-1H-indoler, -indoliner og belægtede forbindelser